+ Chromogenix Coamatic Factor VIII   (K822585)
+ Chromogenix Coatest SP Factor VIII   (K824086)
+ Chromogenix Coatest SP4 Factor VIII   (K824094)

Main Features:


+ In complete compliance with the European Pharmacopoeia chromogenic reference method for analysis of factor VIII concentrates


+ Co-lyophilization of reagents for convenient handling


+ Inclusion of Thrombin for immediate activation of factor VIII


+ Reliable tool for hemophilia classification; no interference from heparin levels up to 1.0 IU/ml


+ S-2765, the most sensitive factor Xa-substrate


+ Instrument applications available FDA cleared


Suitable For:


+ Potency determination of factor VIII concentrates in quality control


+ Hemophilia diagnosis and monitoring


+ Thrombophilia screening (elevated factor VIII)

Main Features:


+ The first validated chromogenic assay for factor VIII activity


+ Stable and robust reagents which contributes to make this the most common chromogenic assay in QC worldwide


+ High flexibility in setting optimal experimental conditions


+ In compliance with the European Pharmacopoeia chromogenic reference method for analysis of factor VIII concentrate


+ Designed for high volume (Coatest SP FVIII) or low volume (Coatest SP4 FVIII) testing FDA cleared

 

Suitable For:


+ Potency determination of factor VIII concentrates in quality control


+ Hemophilia diagnosis and monitoring

Kit

Substrate Type of Samples Measuring Ranges No. of Tests
Chromogenix Coamatic Factor VIII S-2765 Human plasma

Blood fractions

Purified preparations

Elevated: 1-4 IU/ml

Normal: 0.05-1.5 IU/ml

Low: 0.005-0.05 IU/ml

Test tube: 30

Microplate: 120

Automated: up to 100

Chromogenix Coatest SP Factor VIII

Chromogenix Coatest SP4 Factor VIII

S-2765 Human plasma

Blood fractions

Purified preparations

Normal: 0.2-1.5 IU/ml

Low: 0.01-0.2 IU/ml

Test tube: 60

Microplate: 240

Automated: up to 200

Distributed in North America by: DiaPharma Group, Inc.